PLEXUS CORP's CEO Sells 1,500 Shares at $134.54 per Share

Plexus Corp (PLXS) has disclosed that Kelsey Todd P, Director, President, and CEO, has executed a transaction involving the sale of 1,500 shares at a price of $134.54 per share on September 2, 2025.

Plexus Corp (PLXS) announced that Kelsey Todd P, the company's Director, President, and CEO, executed a transaction involving the sale of 1,500 shares at a price of $134.54 per share on September 2, 2025. This sale comes amidst the company's robust financial performance in the second quarter of 2025, which saw Plexus report a return on invested capital (ROIC) of 13.7%, outperforming its weighted average cost of capital (WACC) by 480 basis points [1].

The sale of shares by Todd P follows a period of strong financial results. Plexus achieved a non-GAAP operating margin of 5.7%, generated $16.5 million in free cash flow, and maintained a cash conversion cycle of 68 days [1]. These metrics underscore the company's operational efficiency and liquidity, which are key factors in its ability to execute strategic initiatives such as its $12.2 million share repurchase program [3].

The healthcare/life sciences segment, contributing 42% of total revenue, has emerged as a key growth driver for Plexus. A $205 million annualized contract win in this sector signals long-term partnerships in high-margin industries [1]. This strategic focus on healthcare and aerospace/defense positions Plexus to mitigate sector-specific risks such as supply chain disruptions and cybersecurity threats.

Despite mixed return on capital employed (ROCE) trends over the past five years, Plexus's ROIC of 13.7% and projected 2025 EPS growth of 26% outpace sector averages [1, 4]. The company's ability to secure $205 million in annualized revenue from new programs and its 4.8% economic return further bolster its long-term investment case [1].

The sale of shares by Todd P may signal confidence in Plexus's future prospects, given the company's strong operational performance and strategic positioning. However, it is essential to consider the potential impact on the company's leadership and future strategic direction. For investors, this transaction should be evaluated in the context of Plexus's overall financial health and long-term growth prospects.

References:
[1] Plexus Announces Fiscal Second Quarter Financial Results [https://investor.plexus.com/news/news-details/2025/Plexus-Announces-Fiscal-Second-Quarter-Financial-Results/default.aspx]
[2] Plexus (PLXS) Balance Sheet & Financial Health Metrics [https://simplywall.st/stocks/us/tech/nasdaq-plxs/plexus/health]
[3] Plexus (PLXS) Reports Q2 Earnings [https://finance.yahoo.com/news/plexus-plxs-reports-q2-earnings-233011767.html]
[4] Plexus (NasdaqGS:PLXS) Stock Valuation [https://simplywall.st/stocks/us/tech/nasdaq-plxs/plexus/valuation]
[5] Plexus (PLXS): Assessing Valuation After Q3 Earnings [https://simplywall.st/stocks/us/tech/nasdaq-plxs/plexus/news/plexus-plxs-assessing-valuation-after-q3-earnings-beat-and-2]
[6] 2025 Electronic Supply Chain Predictions [https://simcona.com/blog/supply-chain-challenges-in-the-electronics-industry]